ArticleCancerPublished
Single-agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM-2 trial
Regional connection
Verified Author affiliations on the Europe PMC record name GSK, University of Pennsylvania. Affiliation source
- Institutions
- GSK, University of Pennsylvania
- Counties
- Montgomery County, Philadelphia County
Publication record
- Type
- Article
- Venue
- Cancer
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Multiple Myeloma; Treatment Outcome; Quality of Life; Antibodies, Monoclonal, Humanized; Monoclonal antibody; Multiple myeloma; Clinical Activity; Antibody-drug Conjugate; B-cell Maturation Antigen
- PubMed ID
- 37622738
- PubMed Central ID
- PMC11055177
- Open access
- Yes, open
- Added to directory
- Source checked